Re-watch the webinar
CONTROVERSIES IN ANTIRETROVIRAL TREATMENT
Dr. Calvin Cohen, M.D., M.Sc.,
Executive Director, HIV Medical Affairs, Gilead Sciences, Foster City, CA
About the Speaker
Calvin Cohen, M.D., M.Sc. is an Executive Director within the Medical Affairs department of Gilead Sciences. He joined Gilead in February 2015. His primary role within Medical Affairs is serving as the Global Medical Lead for tenofovir alafenamide, and the portfolio of regimens based on TAF.
Dr. Cohen received his MD degree from the Albert Einstein College of Medicine in New York. He received his Master of Science degree from the Harvard School of Public Health, and completed his residence and fellowship at Beth Israel Hospital in Boston, USA.
Prior to joining Gilead, Dr. Cohen’s research focus was on HIV antiretrovirals trials since 1985. He served as the Director of Research for the non-profit Community Research Initiative of New England which was a site for the NIH funded Community based Trials network. He maintained an Internal Medicine practice focussed on HIV for 30 years within the Harvard system was a part-time Clinical Instructor at Harvard Medical School.
In this webinar, Dr. Calvin Cohen discusses different issues and
controversies in antiretroviral treatment, including:
- weight gain data
- mental health issues
- CVD risk among PLHIV
- resistance and inflammatory markers
*Doctrina d.o.o. takes care of the optimized educational process for people employed in pharmaceutical companies, for doctors, pharmacists,
nurses and other medical staff. All processes are conducted in accordance with the
General Regulation on Personal Data Protection (GDPR).
Learn more in our general terms and conditions.